Cg Oncology, Inc.盘中异动早盘快速下挫5.02%报40.90美元

市场透视10-22

北京时间2025年10月22日23时14分，Cg Oncology, Inc.（CGON.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报40.90美元/股，成交量12.7065万股，换手率0.17%，振幅4.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.43百万美元，每股收益-0.54美元，毛利-156000.00美元，市盈率-22.99倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2577258303?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-10-22 23:14","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2577258303","market":"us","top_or_hot":-1,"title":"Cg Oncology, Inc.盘中异动 早盘快速下挫5.02%报40.90美元","media":"市场透视","content":"<div>\n<p>北京时间2025年10月22日23时14分，Cg Oncology, Inc.（CGON.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报40.90美元/股，成交量12.7065万股，换手率0.17%，振幅4.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.43百万美元，每股收益-0.54美元，毛利-156000.00美元，市盈率-22.99倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223143394d7fed1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cg Oncology, Inc.盘中异动 早盘快速下挫5.02%报40.90美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCg Oncology, Inc.盘中异动 早盘快速下挫5.02%报40.90美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-22 23:14 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223143394d7fed1&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年10月22日23时14分，Cg Oncology, Inc.（CGON.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报40.90美元/股，成交量12.7065万股，换手率0.17%，振幅4.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.43百万美元，每股收益-0.54美元，毛利-156000.00美元，市盈率-22.99倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223143394d7fed1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4135","symbol_name":"资产管理与托管银行","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223143394d7fed1&s=b","article_id":"2577258303","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223143394d7fed1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2577258303","pubTimestamp":1761146073,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年10月22日23时14分，Cg Oncology, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报40.90美元/股，成交量12.7065万股，换手率0.17%，振幅4.39%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为患有膀胱癌的患者开发和商业化一种潜在的骨干膀胱保留治疗方法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4135":"资产管理与托管银行","CGON":"CG Oncology Inc.","BK4139":"生物科技","BCG":"Binah Capital Group Inc"},"translate_title":"Cg Oncology, Inc. fell 5.02% to $40.90 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BCG":1,"CGON":0.9},"content_text":"北京时间2025年10月22日23时14分，Cg Oncology, Inc.（CGON.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报40.90美元/股，成交量12.7065万股，换手率0.17%，振幅4.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-41.43百万美元，每股收益-0.54美元，毛利-156000.00美元，市盈率-22.99倍。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Adaptimmune Therapeutics Plc、Engene Holdings Inc C/Wts 31/10/2028 (To Pur Com) Cl A、Cytomed Therapeutics Limited涨幅较大，Adaptimmune Therapeutics Plc、Rani Therapeutics Holdings, Inc.、Minerva Neurosciences, Inc较为活跃，换手率分别为118.96%、86.20%、34.09%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 (To Pur Com)、Rani Therapeutics Holdings, Inc.，振幅分别为83.54%、62.77%、30.18%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为患有膀胱癌的患者开发和商业化一种潜在的骨干膀胱保留治疗方法。该公司的候选药物 cretostimogene grenadenorepvec 是一种靶向溶瘤膀胱内给药的免疫治疗药物，目前正处于两项三期临床试验（一项高危卡介苗 (BCG) 无反应的非肌层浸润性膀胱癌 (NMIBC) 的试验和一项针对中危 NMIBC 的试验）以及一项针对高危 BCG 无反应性 NMIBC 的检查点抑制剂的二期临床研究。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577258303","isCrawlerRequest":true}

Cg Oncology, Inc.盘中异动 早盘快速下挫5.02%报40.90美元

精彩评论

Cg Oncology, Inc.盘中异动早盘快速下挫5.02%报40.90美元